| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Sto5g0379 | ATGGACGTGAAAAGCAGAGGAATCGCAAtggctttcttcttctttctgggATTTTCTgctattttctctttctctttctcatctGCCAATCAACCTCGTATTACCATAAAGCCAACTCCGAATTATCGCCCCGGCACCTCCGTTGTTTTCCAGGTTCAAGGGAATGTATACCCTCTCGGGTATTACTCAGTGTCCCTTAACATTGGGAATCCCCCTAAAGCTTTTGACCTTGACATTGACTCCGGCAGTGACCTGACGTGGGTACAGTGTGATGCACCGTGTAAAGGTTGCACCAAGCCTCGGGATAAGCAATACAAACCGAAGAAGGAGAACATTGTGAAGTGTGTGGACCCGTTGTGTGCAGGAGTGCAATCATCAGGGAGGCATGATTGTGGTTCCCCAAACGAGCAATGCGATTACGAGGTTGAGTATGCAGACGATGGTTCGTCTCTGGGTGTGCTGGTGCGAGACTATATTCCGCTTGGCTTCGTCAATGGCTCCACCCTACGTGAAAGGGTGGGGTTTGGGTGTGGGTATGATCAAAAGTATTCAGATGCACCATCAACCGCAGGAGTGTTGGGCCTTGGGAACGGGAAGGCAAGCTTTGTGTCACAGCTTAGTTCAATGGGTGTGATTCGTAATGTTGTGGGCCATTGCTTCAGTGCCCGTGGGGGAGGCTTTTTGTTTTTTGGAGATCATCTCCTTCCCTCCTCTGGAGTTTCTTGGATGCCAATTTTGACTGCGTCTTCTGCAAAACACTACATGACGGGACCAGTGGATGTGGTTTTCAATGGAAAAGCTACAAGTGTGAAGGATCTTCAAGTTATCTTCGACAGTGGGAGCTCCTACTCGTACTTCAATTCACAAGCTTACCAAGCCATTGTTAATACGATAGTCAATGATTTAAAGGGAAAGCAATTGAGTAGAGCAACTGCAGATCGTTCCCTTCCACTTTGCTGGAAGGGCGCAAAGCCTTTCAAGTCTTTAAGTGACGTCACCATCTATTTTAAGCCCTTAACACTGAGCTTCACAAGGACTAGGAATTTGCAGCTTCAACTGCCACCACCCGCTTATCTCATTCTCACCAAATATGGCAATGTCTGCTTGGGAATTCTGAACGGCGCTGAAGCTGGACTAGGAAATCTCAACATAATTGGAGATATCTTTTTACAAGATAAAATGGTGATTTATGACAACGAGAAAAAGCAGATTGGATGGGTTTCGGCCAATTGCGATAGGGTTCCCAAGTAA | 1251 | 0.45 | MDVKSRGIAMAFFFFLGFSAIFSFSFSSANQPRITIKPTPNYRPGTSVVFQVQGNVYPLGYYSVSLNIGNPPKAFDLDIDSGSDLTWVQCDAPCKGCTKPRDKQYKPKKENIVKCVDPLCAGVQSSGRHDCGSPNEQCDYEVEYADDGSSLGVLVRDYIPLGFVNGSTLRERVGFGCGYDQKYSDAPSTAGVLGLGNGKASFVSQLSSMGVIRNVVGHCFSARGGGFLFFGDHLLPSSGVSWMPILTASSAKHYMTGPVDVVFNGKATSVKDLQVIFDSGSSYSYFNSQAYQAIVNTIVNDLKGKQLSRATADRSLPLCWKGAKPFKSLSDVTIYFKPLTLSFTRTRNLQLQLPPPAYLILTKYGNVCLGILNGAEAGLGNLNIIGDIFLQDKMVIYDNEKKQIGWVSANCDRVPK | 416 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Sto5g0379 | 416 | SUPERFAMILY | Acid proteases | 54 | 414 | IPR021109 | - | |
| Sto5g0379 | 416 | Pfam | Xylanase inhibitor N-terminal | 62 | 232 | IPR032861 | - | |
| Sto5g0379 | 416 | Gene3D | Acid Proteases | 234 | 414 | IPR021109 | - | |
| Sto5g0379 | 416 | ProSitePatterns | Eukaryotic and viral aspartyl proteases active site. | 275 | 286 | IPR001969 | GO:0004190|GO:0006508 | |
| Sto5g0379 | 416 | Pfam | Xylanase inhibitor C-terminal | 271 | 406 | IPR032799 | - | |
| Sto5g0379 | 416 | Gene3D | Acid Proteases | 40 | 232 | IPR021109 | - | |
| Sto5g0379 | 416 | ProSitePatterns | Eukaryotic and viral aspartyl proteases active site. | 77 | 88 | IPR001969 | GO:0004190|GO:0006508 | |
| Sto5g0379 | 416 | ProSiteProfiles | Peptidase family A1 domain profile. | 62 | 407 | IPR033121 | - | |
| Sto5g0379 | 416 | PANTHER | EUKARYOTIC ASPARTYL PROTEASE FAMILY PROTEIN | 2 | 414 | - | - | |
| Sto5g0379 | 416 | PRINTS | Pepsin (A1) aspartic protease family signature | 68 | 88 | IPR001461 | GO:0004190|GO:0006508 | |
| Sto5g0379 | 416 | PRINTS | Pepsin (A1) aspartic protease family signature | 275 | 286 | IPR001461 | GO:0004190|GO:0006508 | |
| Sto5g0379 | 416 | PRINTS | Pepsin (A1) aspartic protease family signature | 383 | 398 | IPR001461 | GO:0004190|GO:0006508 | |
| Sto5g0379 | 416 | PANTHER | ASPARTYL PROTEASES | 2 | 414 | IPR001461 | GO:0004190|GO:0006508 |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Sto5g0379 | Sto-Chr5 | 2349204 | 2351264 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Sto5g0379 | 46 | 416 | Miscellaneous Gene Families | AT1G44130 | 60.267 | 2.38e-166 | 471 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Sto5g0379 | - | - | aprc:113846122 | 578.556 |